liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease
Oslo University Hospital, Norway .
Umeå University, Sweden .
Drammen Hospital, Norway .
Region Östergötland, Center for Diagnostics, Department of Clinical Chemistry.
Show others and affiliations
2013 (English)In: Neurobiology of Aging, ISSN 0197-4580, E-ISSN 1558-1497, Vol. 34, no 6, 1708.e7-1708.e13 p.Article in journal (Refereed) Published
Abstract [en]

Genome-wide association studies have identified a number of susceptibility loci in sporadic Parkinsons disease (PD). Recent larger studies and meta-analyses have greatly expanded the list of proposed association signals. We performed a case-control replication study in a Scandinavian population, analyzing samples from 1345 unrelated PD patients and 1225 control subjects collected by collaborating centers in Norway and Sweden. Single-nucleotide polymorphisms representing 18 loci previously reported at genome-wide significance levels were genotyped, as well as 4 near-significant, suggestive, loci. We replicated 11 association signals at p andlt; 0.05 (SNCA, STK39, MAPT, GPNMB, CCDC62/HIP1R, SYT11, GAK, STX1B, MCCC1/LAMP3, ACMSD, and FGF20). The more recently nominated susceptibility loci were well represented among our positive findings, including 3 which have not previously been validated in independent studies. Conversely, some of the more well-established loci failed to replicate. While future meta-analyses should corroborate disease associations further on the level of common markers, efforts to pinpoint functional variants and understand the biological implications of each risk locus in PD are also warranted.

Place, publisher, year, edition, pages
Elsevier, 2013. Vol. 34, no 6, 1708.e7-1708.e13 p.
Keyword [en]
Parkinsons disease, GWAS, Genetic association study, Single-nucleotide polymorphism
National Category
Engineering and Technology
Identifiers
URN: urn:nbn:se:liu:diva-92688DOI: 10.1016/j.neurobiolaging.2012.10.019ISI: 000317417100022OAI: oai:DiVA.org:liu-92688DiVA: diva2:621679
Available from: 2013-05-16 Created: 2013-05-16 Last updated: 2017-06-19Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Dizdar, Nil

Search in DiVA

By author/editor
Dizdar, Nil
By organisation
Department of Clinical Chemistry
In the same journal
Neurobiology of Aging
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 43 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf